CORT vs. IOVA
CORT (Corcept Therapeutics Incorporated) and IOVA (Iovance Biotherapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, CORT returned 31.34%/yr vs -6.39%/yr for IOVA. At a 0.22 correlation, their price movements are largely independent.
Performance
CORT vs. IOVA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CORT achieves a 129.05% return, which is significantly higher than IOVA's 48.72% return. Over the past 10 years, CORT has outperformed IOVA with an annualized return of 31.34%, while IOVA has yielded a comparatively lower -6.39% annualized return.
CORT
- 1D
- -0.25%
- 1M
- 32.36%
- YTD
- 129.05%
- 6M
- -6.34%
- 1Y
- 11.67%
- 3Y*
- 53.92%
- 5Y*
- 29.06%
- 10Y*
- 31.34%
IOVA
- 1D
- 3.84%
- 1M
- -1.22%
- YTD
- 48.72%
- 6M
- 46.04%
- 1Y
- 105.05%
- 3Y*
- -20.47%
- 5Y*
- -30.33%
- 10Y*
- -6.39%
CORT vs. IOVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 129.05% | -30.94% | 55.14% | 59.92% | 2.58% | -24.31% | 116.20% | -9.43% | -26.02% | 148.76% |
IOVA Iovance Biotherapeutics, Inc. | 48.72% | -63.11% | -8.98% | 27.23% | -66.53% | -58.86% | 67.63% | 212.77% | 10.62% | 15.11% |
Correlation
The correlation between CORT and IOVA is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Oct 15, 2010 | 0.22 |
Fundamentals
CORT:
$8.32B
IOVA:
$1.70B
CORT:
$0.41
IOVA:
-$0.93
CORT:
12.03
IOVA:
5.42
CORT:
13.05
IOVA:
2.35
CORT:
$769.10M
IOVA:
$285.61M
CORT:
$755.64M
IOVA:
$327.04M
CORT:
$3.66M
IOVA:
-$325.45M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CORT vs. IOVA — Risk / Return Rank
CORT
IOVA
CORT vs. IOVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Iovance Biotherapeutics, Inc. (IOVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CORT | IOVA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.89 | ||
| Sortino ratioReturn per unit of downside risk | -1.38 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.24 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 0.18 | 1.94 | -1.76 |
| Martin ratioReturn relative to average drawdown | 0.33 | 3.05 | -2.72 |
Loading charts...
Drawdowns
CORT vs. IOVA - Drawdown Comparison
The maximum CORT drawdown since its inception was -94.29%, smaller than the maximum IOVA drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for CORT and IOVA.
Loading charts...
Drawdown Indicators
| CORT | IOVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.29% | -99.37% | +5.08% |
Max Drawdown (1Y)Largest decline over 1 year | -64.40% | -54.41% | -9.99% |
Max Drawdown (3Y)Largest decline over 3 years | -71.85% | -90.50% | +18.65% |
Max Drawdown (5Y)Largest decline over 5 years | -71.85% | -93.99% | +22.14% |
Max Drawdown (10Y)Largest decline over 10 years | -71.85% | -96.84% | +24.99% |
Current DrawdownCurrent decline from peak | -30.21% | -97.45% | +67.24% |
Average DrawdownAverage peak-to-trough decline | -53.43% | -84.18% | +30.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.39% | 34.61% | +0.78% |
Volatility
CORT vs. IOVA - Volatility Comparison
The current volatility for Corcept Therapeutics Incorporated (CORT) is 13.61%, while Iovance Biotherapeutics, Inc. (IOVA) has a volatility of 25.62%. This indicates that CORT experiences smaller price fluctuations and is considered to be less risky than IOVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CORT | IOVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.61% | 25.62% | -12.01% |
Volatility (6M)Calculated over the trailing 6-month period | 85.06% | 64.08% | +20.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.18% | 101.54% | -24.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.59% | 89.88% | -15.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 67.22% | 81.44% | -14.22% |
Dividends
CORT vs. IOVA - Dividend Comparison
Neither CORT nor IOVA has paid dividends to shareholders.
Financials
CORT vs. IOVA - Financials Comparison
This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Iovance Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CORT and IOVA have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IOVA has higher volatility (25.62%) compared to CORT (13.61%). In terms of maximum drawdown, CORT dropped -94.29% vs IOVA's -99.37%.
IOVA currently has the higher Sharpe Ratio (1.04 vs 0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CORT and IOVA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer